Evidence map›Paper›PMID 23783413›Full record

ReviewGlycoconjugate journal2013

IgG-Fc N-glycosylation at Asn297 and IgA O-glycosylation in the hinge region in health and disease.

Jing Xue, Li-Ping Zhu, Qiang Wei

Abstract readReview
PubMed Publisher
In one paragraph

Review in Glycoconjugate journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Recombinant Proteins and Monoclonal Antibodies.Advances in biochemical engineering/biotechnology · 2021
    Review
  10. Article
  11. Article
  12. Considerations for the Design of Antibody-Based Therapeutics.Journal of pharmaceutical sciences · 2020
    Review
  13. Improving Immunotherapy Through Glycodesign.Frontiers in immunology · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Advances in recombinant antibody manufacturing.Applied microbiology and biotechnology · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jing XueInstitute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) and Comparative Medicine Center, Peking Union Medical College (PUMC), Key Laboratory of Human Disease Comparative Medicine, No 5 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Li-Ping Zhu
Qiang Wei
Chinese Academy of Medical Sciences & Peking Union Medical College · CNInstitute of Laboratory Animal Science · CNPeking Union Medical College Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulins (Igs) are the major molecules secreted by B lymphocytes during an adaptive immune response. They are glycoproteins with distinctive glycosylation patterns, resulting in wide variations in the number, type and location of their oligosaccharides in each isotype and subclass. The sugars play specific structural roles, maintaining and modulating effector functions of Igs. Aberrant glycosylation might contribute to disease pathogenesis. This review will focus on the glycosylation of IgG and IgA because they have been studied more extensively than other immunoglobulins. Rheumatoid arthritis and IgA nephritis are used to describe the association of glycosylation aberration and disease pathogenesis.

Indexed as

AcetylglucosamineAnimalsArthritis, RheumatoidAsparagineGlycosylationHumansImmunoglobulin AImmunoglobulin Fc FragmentsImmunoglobulin GNephritisAcetylglucosamineAsparagineImmunoglobulin AImmunoglobulin Fc FragmentsImmunoglobulin G

Identifiers

PMID23783413
OpenAlexW1995995495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.